Pharmacological Therapeutic Monitoring of Three Major Anti-Epileptic Drugs in Mali
Abstract
Introduction: Therapeutic drug monitoring is a means of monitoring anti-epileptic treatment. The objective of this study was to conduct therapeutic drug monitoring of the three most commonly prescribed anti-epileptic drugs in Mali.
Methods: This was a cross-sectional, prospective study conducted over an eight-month period. It focused on the pharmacological therapeutic follow-up of carbamazepine (CBZ), phenobarbital (PB), and valproic acid (VPA) in 80 epilepsy patients monitored at the Neurology Department of Point G University Hospital.
Results: The majority of participants were aged between 18 and 70 (65%). Generalised motor seizures were more common (76.20%). Carbamazepine was the most commonly prescribed drug (60.32%), followed by phenobarbital (20.63%) and valproic acid (19.05%). The combination of CBZ/PB was the most commonly observed, at 47.06%. Among patients taking carbamazepine, 2% were underdosed and 23% were overdosed. 75% of patients taking phenobarbital were underdosed. Half of patients taking valproic acid were underdosed and 5% were overdosed.
Conclusion: Pharmacological therapeutic monitoring is an indispensable tool in the management of epilepsy. However, efforts must be made to introduce this practice into routine healthcare in Mali.
Keywords: Therapeutic monitoring, Carbamazepine, Phenobarbital, Valproic acid, Mali
Keywords:
Therapeutic monitoring, Carbamazepine, Phenobarbital, Valproic acid, MaliDOI
https://doi.org/10.22270/jddt.v16i3.7606References
1. Beghi, E. The Epidemiology of Epilepsy. Neuroepidemiology 2019;54:185-191. https://doi.org/10.1159/000503831 PMid:31852003 PMCid:PMC12038215
2. Tuchila, C. et al. Therapeutic Drug Monitoring and Methods of Quantitation for Carbamazepine. Journal of Mind and Medical Sciences 2017;4:100-114. https://doi.org/10.22543/7674.42.P100114
3. Sangare, M. et al. Epilepsy Research in Mali: A Pilot Pharmacokinetics Study on First-Line Antiepileptic Drug Treatment. J Epilepsy Res 2020;10:31-39. https://doi.org/10.14581/jer.20006 PMid:32983953 PMCid:PMC7494886
4. Singh, A. & Roy, V. Therapeutic Drug Monitoring (TDM) in Clinical Practice. Journal, Indian Academy of Clinical Medicine 2025;26:195.
5. Žigová, L., Göböová, M., Hrubá, O., Gažová, A. & Kosírová, S. Treatment stability of valproate, carbamazepine, and levetiracetam: a therapeutic drug monitoring study. Pharmacia 2025;72:1-7. https://doi.org/10.3897/pharmacia.72.e159728
6. Sommerfeld-Klatta, K., Zielińska-Psuja, B., Karaźniewcz-Łada, M. & Główka, F. K. New Methods Used in Pharmacokinetics and Therapeutic Monitoring of the First and Newer Generations of Antiepileptic Drugs (AEDs). Molecules 2020;25:5083. https://doi.org/10.3390/molecules25215083 PMid:33147810 PMCid:PMC7663638
7. Lim, S.-N. et al. Clinical impact of therapeutic drug monitoring for newer anti-seizure medications in patients with epilepsy: A real-world observation study. Biomedical Journal 2024;47:100680. https://doi.org/10.1016/j.bj.2023.100680 PMid:38036171 PMCid:PMC11402380
8. Eshiet, U. I., Ubaka, C. M. & Ukwe, C. V. Infrequent Monitoring of the Effects of Valproate and Carbamazepine Therapy in Patients With Epilepsy in Nigeria. J Cent Nerv Syst Dis 2020;12:1179573520925934. https://doi.org/10.1177/1179573520925934 PMid:32536783 PMCid:PMC7268118
9. Gurshaw, M., Agalu, A. & Chanie, T. Anti-epileptic drug utilization and treatment outcome among epileptic patients on follow-up in a resource poor setting. Journal of Young Pharmaceutics 2014;6:47. https://doi.org/10.5530/jyp.2014.3.8
10. Pal, A., Prusty, S. K., Sahu, P. K. & Swain, T. Drug utilization pattern of antiepileptic drugs: a pharmacoepidemiologic and pharmacovigilance study in a tertiary teaching hospital in India. Asian J Pharm Clin Res 2011;4:96-99.
11. Ejeliogu, E. U. & Uhunmwangho-Courage, A. Pattern of Adverse Drug Reaction to Antiepileptic Drugs at a Tertiary Hospital in North-Central Nigeria: A Prospective Observational Study. Journal of Advances in Medical and Pharmaceutical Sciences 2017;14:1-9. https://doi.org/10.9734/JAMPS/2017/35337
12. ArulKumaran, K. S. G., Palanisamy, S. & Rajasekaran, A. A study on drug use evaluation of anti-epileptics at a multispecialty tertiary care teaching hospital. Int J Pharm Tech Res 2009;1:1541-7.
13. Grześk, G. et al. Therapeutic drug monitoring of carbamazepine: A 20-year observational study. Journal of Clinical Medicine 2021;10:5396. https://doi.org/10.3390/jcm10225396
PMid:34830678 PMCid:PMC8621251
14. Uskur, T. & Güven, O. Therapeutic drug monitoring of carbamazepine and valproic acid: interindividual variability in epilepsy patients. Journal of Health Sciences and Medicine 2025;8:884-888. https://doi.org/10.32322/jhsm.1751139
15. Babaei, A. & Eslamai, M. H. Evaluation of therapeutic drug level monitoring of phenobarbital, phenytoin and carbamazepine in Iranian epileptic patients. International journal of clinical pharmacology and therapeutics 2007;45:121-125. https://doi.org/10.5414/CPP45121 PMid:17323792
16. Ozunal, Z. G. & İpek, B. O. Therapeutic Drug Monitoring Characteristics in a Tertiary University Hospital in 2019. Cureus 12, (2020). https://doi.org/10.7759/cureus.7612
17. Enríquez-Cáceres, M. & Soto-Santillana, M. Non-compliance with pharmacological treatment in patients with epilepsy. Revista de neurologia 2006;42:647-654. https://doi.org/10.33588/rn.4211.2005533 PMid:16736399
18. Wang, W. Z. et al. Efficacy assessment of phenobarbital in epilepsy: a large community-based intervention trial in rural China. The Lancet Neurology 2006;5:46-52. https://doi.org/10.1016/S1474-4422(05)70254-4 PMid:16361022
Published
Abstract Display: 183 
PDF Downloads: 142 PDF Downloads: 18 How to Cite
Issue
Section
Copyright (c) 2026 Mohamed TOURE , Adama Seydou SISSOKO , Mahamadou BALLO, Sékou BAH
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.